Abstract
Immune Profiling of Multiple Myeloma Patients Treated with Daratumumab Monotherapy: Acquired and Primary Daratumumab-Resistance Is Associated with NK Cell Exhaustion
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have